HARRIS TODD (Chief Executive Officer) sold 1.1% of their position (16.31K shares) of TYRA BIOSCIENCES, INC. on the open market
Open‑market sale worth $394.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/20/2024ACC: 0000950170-24-108533
DirectorOfficer· Chief Executive Officer
Since Sep 2021
-16.31K
Net shares
Net seller
$394.4K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
16.31K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−3.50K
Price / share
$24.00
Trade value
$84K
% of position
0.2%
9/18/2024
1.51M→1.50M
Common Stock
Direct
Shares
−5.67K
Price / share
$24.30
Trade value
$137.81K
% of position
0.4%
9/19/2024
1.50M→1.50M
Common Stock
Direct
Shares
−27.00
Price / share
$25.10
Trade value
$677.62
% of position
0.0%
9/19/2024
1.50M→1.50M
Common Stock
Direct
Shares
−7.11K
Price / share
$24.19
Trade value
$171.95K
% of position
0.5%
9/20/2024
1.50M→1.49M
Total
Net shares
−16.31K
Net value
-$394.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/18/2024 | S · Sale | −3.50K | $24.00 | $84K | 0.2% | 1.51M | 1.50M |
| Common Stock Direct | 9/19/2024 | S · Sale | −5.67K | $24.30 | $137.81K | 0.4% | 1.50M | 1.50M |
| Common Stock Direct | 9/19/2024 | S · Sale | −27.00 | $25.10 | $677.62 | 0.0% | 1.50M | 1.50M |
| Common Stock Direct | 9/20/2024 | S · Sale | −7.11K | $24.19 | $171.95K | 0.5% | 1.50M | 1.49M |
| Total | −16.31K | -$394.44K | ||||||
Derivative Transactions0
No derivative transactions reported